Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-03

Clinical Trial Update: Efficacy and Tolerability of DITROPAN XL (Oxybutynin Chloride) Versus DETROL LA (Tolterodine Tartrate) in Treatment of Overactive Bladder [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Ditropan XL (oxybutynin chloride) to Detrol LA (tolterodine tartrate) for overactive bladder, reporting efficacy and tolerability. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Detrol LA (tolterodine tartrate)
  • Ditropan XL (oxybutynin chloride)

Snippet

Sponsor: Alza Corporation, DE, USA | Conditions: Urinary Incontinence | Phase 3 | Status: COMPLETED